1. Home
  2. INVA

INVA

Innoviva Inc.

Logo Innoviva Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 10:30am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Founded: N/A Country:
United States
United States
Employees: 112 City: BURLINGAME
Market Cap: 923.1M IPO Year: 2004
Target Price: $22.50 AVG Volume (30 days): 684.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 2.20 EPS Growth: -7.17
52 Week Low/High: $11.24 - $16.86 Next Earning Date: 05-07-2024
Revenue: $310,463,000 Revenue Growth: -6.30%
Revenue Growth (this year): 4.96% Revenue Growth (next year): 15.01%

Share on Social Networks: